Why the study?
Does vasodilator therapy improve tissue perfusion as measured by 31P NMR spectroscopy in patients with peripheral arterial occlusive disease?
Does vasodilator therapy improve tissue perfusion as measured by 31P NMR spectroscopy in patients with peripheral arterial occlusive disease?
31P NMR spectroscopy can noninvasively detect impaired muscle metabolism in peripheral arterial disease and measure improvements following vasodilator therapy.
Answers are grounded in this paper and cite their sources.
May indicate vasodilator effects on muscle metabolism in PAD; extends 31P NMR utility but leaves open randomized confirmation.
Using 31P nuclear magnetic resonance spectroscopy of the calf muscle, the authors studied patients with peripheral arterial occlusive disease. They studied PCr depletion and intracellular pH during aerobic exercise in patients and controls. The phosphocreatine (PCr) index ([PCr]/([PCr] + [Pi])) at rest was correlated with blood flow measured by plethysmography. During aerobic exercise a greater decrease in pH was obtained in patients (p < 0.03). They also studied the work necessary to reach a PCr index = 0.5 during ischemic exercise. This workload was lower in patients than in controls: 32.99 +/- 3.04 J vs 58.89 +/- 8.55 J, p < 0.05. After vasodilator therapy the workload was improved in patients: 32.99 +/- 3.04 J vs 38.85 +/- 3.54 J, p < 0.05. These results suggest that therapy resulted in improved tissue perfusion in patients.
No takes yet. Share an insight, caveat, or question.
Wahl et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: